A Medical First: Personalized Gene-Editing Treatment for an Infant
Medical Breakthrough: Researchers developed a personalized gene-editing therapy in just six months to correct a life-threatening genetic defect in a newborn with a rare and fatal disease.
In a recent study, researchers successfully engineered the common parasite Toxoplasma gondii to secrete a specific protein into the brain cells of mice.